Arkolith/Insider Trading/PRTK/Form 4

Bigham Michael

Exec. Chairman of the Board, DirectorParatek Pharmaceuticals, Inc. (PRTK) · full profile →Form 4 · filed Aug 10, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$69K
Net Open-Market Flow
-$69K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 9, 2023Sell(S)31K$2.20$69K1.3M
Aug 8, 2023Grant(A)156K—$01.4M

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000904454-23-000476) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML